In focus · trending topic

Acute Myeloid Leukemia

114 stories · following the connections

Actinium Announces Proposed Public Offering of Common Stock

By Nasdaq OMXSep 28, 2016, 8:10 PM UTC

Actinium Announces Initiation of Phase 2 Clinical Trial of Actimab-A in Patients Newly Diagnosed with Acute Myeloid Leukemia Over Age 60

By Nasdaq OMXSep 27, 2016, 11:00 AM UTC

Actinium Pharmaceuticals to Sponsor and Participate in Be The Match® Walk+Run to Raise Awareness for Bone Marrow Transplant

By Nasdaq OMXSep 26, 2016, 11:00 AM UTC

Actinium Pharmaceuticals to Host Webinar to Provide Update on Actimab-A Phase 2 Clinical Trial

By Nasdaq OMXSep 21, 2016, 12:01 PM UTC

Actinium Pharmaceuticals to Host Webinar to Provide Update on Actimab-A Phase 2 Clinical Trial

By Nasdaq OMXSep 21, 2016, 12:01 PM UTC

Actinium Pharmaceuticals Selects Vector Oncology as its Clinical Research Organization for Actimab-A Phase 2 Trial

By Nasdaq OMXSep 20, 2016, 11:02 AM UTC

Actinium Pharmaceuticals to Present at Ladenburg Thalmann 2nd Annual Healthcare Conference

By Nasdaq OMXSep 19, 2016, 11:00 AM UTC

Actinium Pharmaceuticals Presenting at Rodman & Renshaw 18th Annual Global Investment Conference

By Nasdaq OMXSep 13, 2016, 11:00 AM UTC